(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)
- Conditions
- Marginal Zone LymphomaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPeripheral T Cell LymphomaDiffuse Large B Cell LymphomaRichter SyndromeFollicular Lymphoma
- Interventions
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05923502
Arterial Spin Label Depicted Ischemic Stroke Cohort (ASLIS)
- Conditions
- Acute Ischemic Stroke
- Interventions
- Other: routine therapy of acute ischemia stroke
- First Posted Date
- 2023-06-27
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05920902
- Locations
- 🇨🇳
Ruijin hospital, Shanghai, Shanghai, China
Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
- Conditions
- Advanced Pancreatic Cancer
- Interventions
- Biological: Personalized neoantigen tumor vaccine
- First Posted Date
- 2023-06-23
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 54
- Registration Number
- NCT05916261
- Locations
- 🇨🇳
Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Qionghai, Hainan, China
Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
- Conditions
- Advanced Solid Tumor
- Interventions
- Biological: Personalized neoantigen tumor vaccineBiological: PD-1 inhibitor
- First Posted Date
- 2023-06-23
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT05916248
- Locations
- 🇨🇳
Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
- Conditions
- NK/T-Cell Lymphoma, Nasal and Nasal-TypeIntravascular Large B-Cell LymphomaExtranodal LymphomaMucosa-Associated Lymphoid Tissue LymphomaAngioimmunoblastic T-cell LymphomaLymphomaDiffuse Large B Cell LymphomaAnaplastic Large Cell LymphomaMarginal Zone Lymphoma
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT05907447
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Machine Vision Based MDS-UPDRS III Machine Rating
- Conditions
- Parkinsonian DisordersMachine Learning
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 871
- Registration Number
- NCT05906719
- Locations
- 🇨🇳
Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Beijing Hospital, Neurology Department, Beijing, Beijing, China
🇨🇳Department of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China
A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL
- Conditions
- Follicular Lymphoma
- Interventions
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2023-06-12
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 332
- Registration Number
- NCT05899621
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT
- Conditions
- PCNSL
- Interventions
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2023-09-05
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT05896007
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease
- Conditions
- Mild Cognitive ImpairmentMild Dementia
- Interventions
- Behavioral: Diet interventionBehavioral: ExerciseBehavioral: Cognitive training
- First Posted Date
- 2023-06-05
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT05887674
- Locations
- 🇨🇳
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Risk Evaluation by COronary CTA and Artificial intelliGence Based fuNctIonal analyZing tEchniques - I
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05884008
- Locations
- 🇨🇳
First affiliated hospital of Harbin Medical University, Harbin, Heilongjiang, China
🇨🇳Cangzhou Center Hospital, Cangzhou, Hebei, China
🇨🇳First affiliated hospital of Zhengzhou University, Zhengzhou, Henan, China